drugset / Trial / NCT01862887

A Study to Investigate the Effect of PH-797804 on QTc Interval

NCT01862887

Phase 1 Completed 48 enrolled Pfizer
RandomizedCrossoverDouble-blindBasic science

Summary

The purpose of this study is to investigate the effect of PH-797804 following dosing of a 24 mg oral tablet on the QTc interval

Timeline

Start
2013-04
Primary completion
2013-08
Completion
2013-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Moxifloxacin Small molecule 400 mg
Subject PH-797804 Small molecule 24 mg Oral

Indications

No indication recorded.